Obstetrics, gynecology and reproductive medicine guidelines

Hepatitis

Guidelines, reviews, statements, recommendations, standards

 

Alcoholic hepatitis

• Denmark
  • Alcohol and Alcoholism
    • Epidemiology of Alcoholic Liver Disease in Denmark 2006–2011: A Population-Based Study [2015]
• Europe
  • European Association for the Study of the Liver
    • EASL Clinical Practice Guidelines: Management of alcohol-related liver disease [2018]
• India
  • Association of Physicians of India
    • Alcoholic Hepatitis in India: Current Prospective and Management [2017]
• Italy
  • World Journal of Gastroenterology
    • Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement [2014]
• Latin America
  • Annals of Hepatology
    • Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH) [2019]
• Republic of Korea
  • Korean Association for the Study of the Liver
    • KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease [2013]
• United Kingdom
  • Health Technology Assessment
    • The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial [2015]
• United States of America
  • American Association for the Study of Liver Diseases
    • Alcoholic liver disease [2010]
  • American College of Gastroenterology
    • ACG Clinical Guideline: Alcoholic Liver Disease [2018]
  • American Gastroenterological Association
    • Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute [2017]
  • Journal of Clinical and Translational Hepatology
    • Current Management of Alcoholic Hepatitis and Future Therapies [2016]
  • Journal of Clinical Gastroenterology
    • Trends in Alcoholic Hepatitis related Hospitalizations, Financial Burden, and Mortality in the United States [2015]
  • National Institute on Alcohol Abuse and Alcoholism
    • Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia [2016]
• {Related topics}
  • Guidelines
    • Hepatitis

Autoimmune hepatitis

• Asia, Pacific
  • Journal of Clinical and Translational Hepatology
    • Autoimmune Hepatitis in the Asia-Pacific Area [2018]
• Brazil
  • Arquivos de Gastroenterologia
    • Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver [2015]
• Europe
  • European Association for the Study of the Liver
    • EASL Clinical Practice Guidelines: Autoimmune Hepatitis [2015]
  • European Society for Paediatric Gastroenterology Hepatology and Nutrition
    • Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement [2018]
• Germany
  • United European Gastroenterology Journal
    • Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort [2018]
• Greece
  • Annals of Gastroenterology
    • Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis [2019]
• International
  • International Autoimmune Hepatitis Group
    • Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda [2018]
    • Expert clinical management of autoimmune hepatitis in the real world [2017]
    • Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue [2011]
  • World Journal of Gastroenterology
    • Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments [2017]
  • World Journal of Hepatology
    • Autoimmune hepatitis: Appraisal of current treatment guidelines [2018]
• Japan
  • Acta Medica Okayama
    • Current status of autoimmune hepatitis in Japan [2008]
  • Internal Medicine
    • Autoimmune Hepatitis: Recent Advances in the Pathogenesis and New Diagnostic Guidelines in Japan [2015]
• Republic of Korea
  • Clinical and Molecular Hepatology
    • Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea [2018]
• Saudi Arabia
  • Saudi Journal of Gastroenterology
    • The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis [2018]
• United Kingdom
  • British Society of Gastroenterology
    • British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis [2011]
• United States of America
  • American Association for the Study of Liver Diseases
    • Diagnosis and management of autoimmune hepatitis [2010]
  • Modern Pathology
    • Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria [2017]
• {Related topics}
  • Guidelines
    • Hepatitis

Hepatitis

• Africa
  • Journal of Hepatology
    • Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach [2014]
  • WHO Regional Office for Africa
    • End hepatitis by 2030: prevention, care and treatment of viral hepatitis in the African Region: framework for action, 2016-2020 [2017]
    • Hepatitis
• America
  • Pan American Health Organization
    • 2017 Highlights. Hepatitis B and C in the Spotlight: a public health response in the Americas [2017]
• Asia
  • WHO Western Pacific Region
    • First Meeting of Hepatitis Programme Focal Points from High-burden Countries in Asia, Hong Kong SAR (China), 22-24 June 2016 : meeting report [2016]
• Australia
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    • Communicare Administrator Manual: Viral Hepatitis [2015]
  • Australian Family Physician
    • Hepatitis in refugees who settle in Australia [2007]
• Cambodia
  • Euroasian Journal of Hepato-Gastroenterology
    • Viral Hepatitis in Cambodia: Past, Present, and Future [2016]
• Canada
  • BCGuidelines
    • Viral Hepatitis Testing [2012]
  • Canadian Agency for Drugs and Technologies in Health
    • Non-Invasive Methods for Diagnosis and Monitoring of Liver Fibrosis in Patients with Chronic Hepatitis B and C: A Review of Diagnostic Accuracy, Clinical Effectiveness, Cost-Effectiveness and Guidelines [2015]
  • Ontario Association of Medical Laboratories
    • Guidelines for Ordering Diagnostic Testing for Viral Hepatitis [2010]
  • Toward Optimized Practice
    • Serological Testing: Viral Hepatitis [2014]
• China
  • International Journal of Infectious Diseases
    • Systematic review on the reporting quality of randomized controlled trials in patients with hepatitis B or C in China [2018]
  • World Journal of Gastroenterology
    • Clinical characteristics and current management of hepatitis B and C in China [2014]
• Eastern Mediterranean
  • WHO Regional Office for the Eastern Mediterranean
    • Regional action plan for the implementation of the global health sector strategy on viral hepatitis 2017–2021 [2017]
    • Summary report on the strategic and technical consultation on viral hepatitis in the Eastern Mediterranean Region, Casablanca, Morocco, 25–27 April 2016 [2016]
• Eastern Mediterranean, Middle East
  • Hepatitis Monthly
    • Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review [2016]
• Egypt
  • Eastern Mediterranean Health Journal
    • Towards a hepatitis-free Egypt: is this achievable? [2018]
• Egypt, Mauritania
  • World Journal of Gastroenterology
    • Challenge of hepatitis C in Egypt and hepatitis B in Mauritania [2018]
• Ethiopia
  • BMC Public Health
    • Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia [2016]
• Europe
  • BMC Infectious Diseases
    • Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey [2015]
  • Croatian Medical Journal
    • Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe [2016]
  • European Centre for Disease Prevention and Control
    • Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA [2018]
    • Hepatitis B and C testing activities, needs, and priorities in the EU/EEA [2017]
  • EuroSurveillance
    • Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions [2017]
  • International Union against Sexually Transmitted Infections
    • 2017 European Guideline for the screening, prevention and initial management of hepatitis B & C infections in sexual health settings [2017]
  • Journal of Preventive Medicine and Hygiene
    • The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries [2016]
  • WHO Regional Office for Europe
    • Action plan for the health sector response to viral hepatitis in the WHO European Region (2017) [2017]
    • Hepatitis
• India
  • Indian Journal of Medical Research
    • Combating the wrath of viral hepatitis in India [2016]
• International
  • Annals of Hepatology
    • Joint Society statement for elimination of viral hepatitis [2017]
  • BMC Infectious Diseases
    • WHO guidelines on testing for hepatitis B and C – meeting targets for testing [2017]
    • The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing [2017]
    • One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling [2017]
    • Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infection [2017]
  • BMC Public Health
    • Associations between national viral hepatitis policies/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy report [2017]
  • PLoS ONE
    • Cost-Effectiveness of HBV and HCV Screening Strategies – A Systematic Review of Existing Modelling Techniques [2015]
• Japan
  • Euroasian Journal of Hepato-Gastroenterology
    • Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease [2017]
• Kiribati
  • WHO Western Pacific Region
    • Viral hepatitis situation and response in Kiribati 2015 [2017]
• Kyrgyzstan
  • WHO Regional Office for Europe
    • Assessment of the Viral Hepatitis Response in Kyrgyzstan, 11–15 July 2016 (2017) [2017]
• Low and middle-income countries
  • BMC Infectious Diseases
    • Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers [2017]
    • Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries [2017]
• Mongolia
  • Euroasian Journal of Hepato-Gastroenterology
    • Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia [2018]
  • WHO Western Pacific Region
    • Viral hepatitis in Mongolia : situation and response 2015 [2016]
• Netherlands
  • PLoS ONE
    • Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country [2018]
• New Zealand
  • Ministry of Health New Zealand
    • Hepatitis (viral) – not otherwise specified [2017]
• Republic of Korea
  • Japanese Journal of Infectious Diseases
    • The Economic Burden of Hepatitis A, B, and C in South Korea [2016]
• Saudi Arabia
  • Saudi Medical Journal
    • Viral hepatitis in Saudi Arabia. An unfinished story [2015]
• South-East Asia
  • WHO Regional Office for South-East Asia
    • Regional action plan for viral hepatitis in South-East Asia: 2016-2021 [2017]
    • Hepatitis [2017]
    • Regional strategy for the prevention and control of viral hepatitis, 2012: Report of a workshop, New Delhi, India, 11-13 July 2012 [2014]
    • Regional strategy for the prevention and control of Viral Hepatitis [2013]
    • Hepatitis
• Sub-Saharan Africa
  • Centers for Disease Control and Prevention
    • Progress Toward Prevention of Transfusion-Transmitted Hepatitis B and Hepatitis C Infection — Sub-Saharan Africa, 2000–2011 [2014]
• Switzerland
  • Swiss Medical Weekly
    • Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection [2013]
• Taiwan
  • Journal of the Formosan Medical Association
    • Perspectives on dual hepatitis B and C infection in Taiwan [2016]
  • PLoS ONE
    • Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan? [2016]
• United Kingdom
  • British Association for Sexual Health and HIV
    • United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015 [2015]
  • HSC Public Health Agency
    • NI Regional Hepatitis B&C Managed Clinical Network Annual Report 2018 [2018]
  • National Institute for Health and Care Excellence
    • Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C [2015]
    • Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection [2012]
    • Hepatitis
  • Public Health England
    • Investigation of hepatitis
    • Acute infective hepatitis
• Ukraine
  • WHO Regional Office for Europe
    • Assessment of the viral hepatitis response in Ukraine. Mission Report 6-9 June 2017 (2018) [2018]
• United States of America
  • American College of Surgeons
    • Statement on the Surgeon and Hepatitis [2004]
  • Centers for Disease Control and Prevention
    • Viral Hepatitis
    • Hepatitis
    • CDC Division of Viral Hepatitis
  • Minnesota Department of Health
    • Hepatitis
  • National Academies Press
    • Eliminating the Public Health Problem of Hepatitis B and C in the United States [2016]
  • U.S. Department of Veterans Affairs
    • Viral Hepatitis
• Western Pacific
  • WHO Western Pacific Region
    • Informal Consultation on Access to Hepatitis Medicines in Upper-Middle- and High-Income Countries, Manila, Philippines, 21-22 August 2017 : meeting report [2017]
    • Second Meeting of the Strategic Technical Advisory Committee for Viral Hepatitis in the Western Pacific, Hanoi, Viet Nam, 25-27 January 2016 : meeting report [2016]
    • Hepatitis
• WHO
  • World Health Organization
    • Guidelines on hepatitis B and C testing [2017]
    • Global hepatitis report, 2017 [2017]
    • Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework [2016]
    • Global health sector strategy on viral hepatitis 2016-2021 [2016]
    • Combating hepatitis B and C to reach elimination by 2030 [2016]
    • Manual for the development and assessment of national viral hepatitis plans: a provisional document [2015]
    • Consultation with pharmaceutical companies on global access to hepatitis drugs and diagnostics [2014]
    • Guidance on prevention of viral hepatitis B and C among people who inject drugs [2012]
    • Hepatitis
• {Related topics}
  • Guidelines
    • Sexually transmitted infections
    • Hepatitis: epidemiology
    • Hepatitis in pregnancy and newborn
    • Hepatitis G
    • Hepatitis E
    • Hepatitis D
    • Hepatitis C
    • Hepatitis B
    • Hepatitis A
    • HIV/AIDS and hepatitis
    • Autoimmune hepatitis
    • Alcoholic hepatitis

Hepatitis A

• Australia
  • Australasian Sexual Health Alliance
    • Hepatitis A
  • Department of Health Australia
    • Hepatitis A - CDNA National Guidelines for Public Health Units [2018]
  • NSW Ministry of Health
    • Hepatitis A
  • SA Health
    • Hepatitis A for health professionals
• Canada
  • BMC Health Services Research
    • A review of interventions triggered by hepatitis A infected food-handlers in Canada [2006]
  • Government of Alberta
    • Public health disease management guidelines : hepatitis A [2018]
  • Government of Canada
    • Hepatitis A
• Europe
  • European Centre for Disease Prevention and Control
    • Hepatitis A virus in the EU/EEA, 1975–2014 [2016]
• New Zealand
  • Ministry of Health New Zealand
    • Hepatitis A [2018]
• Republic of Korea
  • Epidemiology and Health
    • The costs of hepatitis A infections in South Korea [2014]
• United Kingdom
  • Public Health England
    • SMI V 27: hepatitis A virus acute infection serology
    • Hepatitis A: the green book, chapter 17
    • Hepatitis A: guidance, data and analysis
• United States of America
  • Centers for Disease Control and Prevention
    • Hepatitis A Information
    • Hepatitis A
  • Minnesota Department of Health
    • Hepatitis A
• WHO
  • World Health Organization
    • Collaborative study to evaluate the proposed 3rd WHO international standard for hepatitis A virus (HAV) for nucleic acid amplification technology (NAT)-based assays [2017]
    • Hepatitis A: Fact sheet
• {Related topics}
  • Guidelines
    • Hepatitis A: prevention, vaccine
    • Hepatitis A: epidemiology
    • Hepatitis

Hepatitis A: epidemiology

• Asia, Pacific
  • International Journal of Infectious Diseases
    • Changing sero-epidemiology of hepatitis A in Asia Pacific countries: A systematic review [2018]
• Brazil
  • Memórias do Instituto Oswaldo Cruz
    • Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002 - A Review [2006]
• Brazil, Mexico
  • Human Vaccines & Immunotherapeutics
    • Modeling the hepatitis A epidemiological transition in Brazil and Mexico [2017]
• Canada
  • BMC Infectious Diseases
    • Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review [2005]
• Croatia
  • Hepatitis Monthly
    • Seroepidemiology of Hepatitis A in the Croatian Population [2011]
• Europe
  • European Centre for Disease Prevention and Control
    • Hepatitis A - Annual Epidemiological Report for 2016 [2019]
    • Rapid risk assessment: Multi-country outbreak of hepatitis A virus genotype IA infections affecting EU countries in 2018 [2018]
  • EuroSurveillance
    • Travel-associated hepatitis A in Europe, 2009 to 2015 [2018]
    • Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017 [2018]
    • Changing hepatitis A epidemiology in the European Union: new challenges and opportunities [2015]
    • Hepatitis A in the European Union: responding to challenges related to new epidemiological patterns [2009]
• France
  • EuroSurveillance
    • Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017 [2018]
• International
  • Cold Spring Harbor Perspectives in Medicine
    • Globalization and the Changing Epidemiology of Hepatitis A Virus [2018]
  • EuroSurveillance
    • Usability of the international HAVNet hepatitis A virus database for geographical annotation, backtracing and outbreak detection [2018]
• Iran
  • Journal of Research in Medical Sciences
    • Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran [2014]
• Ireland
  • Health Protection Surveillance Centre
    • Hepatitis A
• Lebanon
  • Avicenna Journal of Medicine
    • Infectious diseases in the era of refugees: Hepatitis A outbreak in Lebanon [2018]
• Low-resource settings
  • Current Opinion in Infectious Diseases
    • Hepatitis A: epidemiology in resource-poor countries [2015]
• Netherlands
  • Journal of Travel Medicine
    • Risk of Hepatitis A Decreased Among Dutch Travelers to Endemic Regions in 2003 to 2011 [2015]
• Republic of Korea
  • Epidemiology and Health
    • Age-period-cohort analysis of hepatitis A incidence rates in Korea from 2002 to 2012 [2016]
  • Journal of Korean Medical Science
    • Hepatitis A in Korea from 2011 to 2013: Current Epidemiologic Status and Regional Distribution [2015]
• Singapore
  • Annals Academy of Medicine Singapore
    • Changing epidemiological patterns of hepatitis A infection in Singapore [2011]
• Syria
  • Iranian Red Crescent Medical Journal
    • Epidemiology of Hepatitis A Virus Infections in Syria, 2017; War and Asylum Seekers: A Global Threat [2017]
• Taiwan
  • EuroSurveillance
    • Outbreak of hepatitis A virus infection in Taiwan, June 2015 to September 2017 [2019]
• Thailand
  • PLoS ONE
    • Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand [2016]
• United States of America
  • Centers for Disease Control and Prevention
    • Increase in Hepatitis A Virus Infections — United States, 2013–2018 [2019]
  • Journal of Infectious Diseases
    • Trends in Disease and Complications of Hepatitis A Virus Infection in the United States, 1999–2011: A New Concern for Adults [2015]
• WHO
  • World Health Organization
    • The global prevalence of hepatitis A virus infection and susceptibility : a systematic review [2010]
• {Related topics}
  • Guidelines
    • Hepatitis: epidemiology
    • Hepatitis A

Hepatitis A: prevention, vaccine

• Australia
  • Australian Family Physician
    • Hepatitis A – prevention in travellers [2010]
  • Department of Health Australia
    • Hepatitis A | The Australian Immunisation Handbook [2018]
  • Vaccine
    • Impact of the national targeted Hepatitis A immunisation program in Australia: 2000–2014 [2016]
• Brazil
  • Cadernos de Saúde Pública
    • Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil [2012]
• Bulgaria
  • Biotechnology & Biotechnological Equipment
    • Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting [2014]
• Canada
  • Government of Canada
    • Hepatitis A Vaccine
  • Public Health Agency of Canada
    • Update on the Recommended use of Hepatitis A Vaccine [2016]
    • Hepatitis A virus (HAV)
  • Public Health Ontario
    • Hepatitis A Post-exposure Prophylaxis [2013]
• China
  • Journal of Epidemiology
    • Development, Production, and Postmarketing Surveillance of Hepatitis A Vaccines in China [2014]
• Germany
  • Scientific Reports
    • Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany [2018]
• Greece
  • PLoS ONE
    • Considerations on the Current Universal Vaccination Policy against Hepatitis A in Greece after Recent Outbreaks [2015]
• Iran
  • Hepatitis Monthly
    • Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers [2015]
• Ireland
  • Ireland's Health Services
    • Hepatitis A [2015]
• Israel
  • EuroSurveillance
    • The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012 [2015]
• Mexico
  • Human Vaccines & Immunotherapeutics
    • Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico [2015]
• Panama
  • Vaccine
    • Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis [2015]
• United Kingdom
  • Public Health England
    • Hepatitis A infection: prevention and control guidance
• United States of America
  • Centers for Disease Control and Prevention
    • Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness [2019]
    • Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel [2018]
    • Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis [2017]
    • Progress Toward Eliminating Hepatitis A Disease in the United States [2016]
    • Surveillance Manual | Hepatitis A
    • Hepatitis A Vaccination
• WHO
  • World Health Organization
    • WHO position paper on hepatitis A vaccines – June 2012 [2012]
    • The immunological basis for immunization series: module 18: hepatitis A [2011]
• {Related topics}
  • Guidelines
    • Hepatitis A

Hepatitis B

• Asia
  • Asia-Pacific Journal of Oncology Nursing
    • Correlates of Hepatitis B Virus-related Stigmatization Experienced by Asians: A Scoping Review of Literature [2016]
• Asia, Pacific
  • Asian Pacific Association for the Study of the Liver
    • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update [2016]
  • Hepatology International
    • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update [2015]
• Australia
  • Australasian Sexual Health Alliance
    • Hepatitis B
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    • B Positive | Hepatitis B for Primary Care [2018]
    • Decision Making in Viral Hepatitis Related Advanced Liver Disease [2016]
    • Decision Making in HBV 2015 [2015]
  • Australian Family Physician
    • Chronic hepatitis B – what’s new? [2013]
    • Hepatitis B serology [2012]
  • Bulletin of the World Health Organization
    • Community-based prevention of hepatitis-B-related liver cancer: Australian insights [2014]
  • Department of Health Australia
    • Hepatitis B - CDNA National Guidelines for Public Health Units [2018]
    • Second National Hepatitis B Strategy 2014-2017 [2014]
    • National HBV Testing Policy [2012]
  • Department of Health Northern Territory Government
    • Northern Territory hepatitis B vaccination and public health guidelines [2013]
  • NSW Ministry of Health
    • Hepatitis B
• Canada
  • Canadian Association for the Study of the Liver
    • Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines [2012]
  • Government of Alberta
    • Public health disease management guidelines: Hepatitis B - acute and chronic [2018]
  • Public Health Agency of Canada
    • Primary Care Management of Hepatitis B [2014]
• China
  • BioMed Research International
    • Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China [2015]
  • Bulletin of the World Health Organization
    • Countdown to 2030: eliminating hepatitis B disease, China [2019]
  • International Journal of Environmental Research and Public Health
    • Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-Analysis [2016]
  • International Journal of Infectious Diseases
    • Helicobacter pylori infection may increase the risk of progression of chronic hepatitis B disease among the Chinese population: a meta-analysis [2016]
• Developing countries
  • World Journal of Hepatology
    • Hepatitis B: Epidemiology and prevention in developing countries [2012]
• Egypt
  • Tropical Gastroenterology
    • Occult hepatitis B: the Egyptian situation [2012]
• Europe
  • Clinical Microbiology and Infection
    • Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe [2015]
  • European Association for the Study of the Liver
    • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [2017]
    • EASL Clinical Practice Guidelines: Management of chronic hepatitis B [2012]
  • European Society for Paediatric Gastroenterology Hepatology and Nutrition
    • Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines [2013]
  • WHO Regional Office for Europe
    • Fact sheet - Hepatitis B in the WHO European Region (2018) [2018]
• Gambia
  • Tropical Medicine and Health
    • Population-Based Interventions to Reduce the Public Health Burden Related with Hepatitis B Virus Infection in The Gambia, West Africa [2014]
• India
  • Journal of Clinical and Translational Hepatology
    • Current Scenario of Hepatitis B and Its Treatment in India [2017]
• Indonesia
  • World Journal of Gastroenterology
    • Current hepatitis B virus infection situation in Indonesia and its genetic diversity [2016]
• International
  • Journal of Hepatology
    • Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs [2015]
  • World Gastroenterology Organisation
    • World Gastroenterology Organisation Global Guideline Hepatitis B: September 2015 [2016]
  • World Journal of Hepatology
    • Hepatitis B in healthcare workers: Transmission events and guidance for management [2015]
• New Zealand
  • Ministry of Health New Zealand
    • Hepatitis B [2012]
• North Korea
  • Journal of Korean Medical Science
    • Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy [2015]
• Republic of Korea
  • International Journal of Molecular Sciences
    • Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants [2015]
  • Korean Association for the Study of the Liver
    • KASL clinical practice guidelines: management of chronic hepatitis B [2016]
• Saudi Arabia
  • Saudi Journal of Gastroenterology
    • SASLT Practice Guidelines for the Management of Hepatitis B Virus [2014]
  • Saudi Medical Journal
    • Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions [2019]
• Taiwan
  • Journal of the Formosan Medical Association
    • Taiwan consensus statement on the management of chronic hepatitis B [2018]
    • Perspectives and control of hepatitis B virus infection in Taiwan [2015]
• Tanzania
  • Journal of Tropical Medicine
    • Hepatitis B Virus Infection in Tanzania: Current Status and Challenges [2018]
• Turkey
  • Turkish Journal of Gastroenterology
    • Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines [2017]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Hepatitis B (chronic): diagnosis and management [2017]
  • Public Health England
    • Hepatitis B: the green book, chapter 18
    • Hepatitis B: guidance, data and analysis
• United States of America
  • Agency for Healthcare Research and Quality
    • Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults [2014]
  • Alimentary Pharmacology & Therapeutics
    • An expert consensus for the management of chronic hepatitis B in Asian Americans [2018]
  • American Association for the Study of Liver Diseases
    • Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance [2018]
  • Centers for Disease Control and Prevention
    • Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students [2012]
    • Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection [2008]
    • Hepatitis B Information
    • Hepatitis B
  • Journal of the American Board of Family Medicine
    • Management of Chronic Hepatitis B: An Overview of Practice Guidelines for Primary Care Providers [2015]
  • Minnesota Department of Health
    • Hepatitis B
  • U.S. Preventive Services Task Force
    • Hepatitis B Virus Infection: Screening, 2014 [2014]
• Western Pacific
  • Bulletin of the World Health Organization
    • Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications [2009]
  • WHO Western Pacific Region
    • Hepatitis B control : country profile 2017 [2018]
    • Fifth Hepatitis B Expert Resource Panel Consultation, Manila, Philippines, 15-17 February 2017 : meeting report [2017]
• WHO
  • World Health Organization
    • Collaborative study to evaluate the proposed WHO 4th International Standard for Hepatitis B Virus (HBV) DNA for Nucleic Acid Amplification Technique (NAT) based assays [2016]
    • Collaborative study to evaluate the proposed 3rd WHO international standards for Hepatitis B Virus (HBV) for Nucleic Acid Amplification Technology (NAT)-Based Assays [2011]
    • Collaborative study to establish a World Health Organization international Hepatitis B virus genotype panel for HBsAG Assays [2011]
    • Collaborative study to establish a World Health Organization international genotype panel for hepatitis B virus nucleic acid amplication technique (NAT)-based assays [2009]
    • Hepatitis B: Fact sheet
• {Related topics}
  • Guidelines
    • Hepatitis B: prevention, treatment, vaccine
    • Hepatitis B: epidemiology
    • Hepatitis

Hepatitis B: epidemiology

• Albania
  • Virology Journal
    • Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009 [2011]
  • World Journal of Gastroenterology
    • Epidemiology of hepatitis B virus infection in Albania [2009]
• Australia
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    • Hepatitis B prevalence and epidemiology in Australia [2018]
    • 2015 Third National Hepatitis B Mapping Report [2016]
  • BMC Infectious Diseases
    • Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis [2013]
• Bahrain
  • PLoS ONE
    • Prevalence and Risk Factors of Hepatitis B Virus Infection in Bahrain, 2000 through 2010 [2014]
• Bangladesh
  • Genes
    • Epidemiology of Hepatitis B Virus Infection in Bangladesh: Prevalence among General Population, Risk Groups and Genotype Distribution [2018]
• Brazil
  • Revista da Sociedade Brasileira de Medicina Tropical
    • Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21st century [2015]
• Burkina Faso
  • BMC Public Health
    • High prevalence of hepatitis B infections in Burkina Faso (1996–2017): a systematic review with meta-analysis of epidemiological studies [2018]
• Canada
  • Public Health Agency of Canada
    • Hepatitis B surveillance in Canada: 2005-2012 [2014]
• China
  • PLoS ONE
    • Trends of Acute Hepatitis B Notification Rates in Eastern China from 2005 to 2013 [2014]
    • A Bayesian Meta-Analysis on Prevalence of Hepatitis B Virus Infection among Chinese Volunteer Blood Donors [2013]
  • Scientific Reports
    • Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China [2017]
• Denmark
  • EuroSurveillance
    • Hepatitis B prevalence in Denmark - an estimate based on nationwide registers and a national screening programme, as on 31 December 2007 [2013]
• Developing countries
  • World Journal of Gastroenterology
    • Hepatitis B virus burden in developing countries [2015]
• Eastern Mediterranean, Middle East
  • Hepatitis Monthly
    • The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis [2016]
• Egypt
  • World Journal of Hepatology
    • Occult hepatitis B virus infection in Egypt [2015]
• Europe
  • BMC Infectious Diseases
    • Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries [2018]
  • European Centre for Disease Prevention and Control
    • Hepatitis B - Annual Epidemiological Report for 2016 [2018]
• Finland
  • Vaccine
    • Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy [2016]
• Gambia
  • PLoS ONE
    • 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa [2013]
• Ghana
  • BMC Infectious Diseases
    • Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015) [2016]
• Greenland
  • American Journal of Epidemiology
    • Hepatitis B Prevalence and Incidence in Greenland: A Population-Based Cohort Study [2015]
• Hong Kong
  • Western Pacific Surveillance and Response Journal
    • Surveillance and response of hepatitis B virus in Hong Kong Special Administrative Region, 1988–2014 [2016]
• India
  • Journal of Clinical and Experimental Hepatology
    • Tackling the Hepatitis B Disease Burden in India [2014]
  • Virology Journal
    • An overview of molecular epidemiology of hepatitis B virus (HBV) in India [2008]
• Indonesia
  • World Journal of Gastroenterology
    • Hepatitis B virus infection in Indonesia [2015]
• International
  • Cold Spring Harbor Perspectives in Medicine
    • Hepatitis B Virus Epidemiology [2015]
  • World Journal of Hepatology
    • Hepatitis B virus infection in immigrant populations [2015]
• Iran
  • Gastroenterology and Hepatology From Bed to Bench
    • Prevalence of hepatitis B virus infection among Iranian high risk groups: a systematic review and meta-analysis [2018]
  • Hepatitis Monthly
    • Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis [2016]
  • Journal of Research in Medical Sciences
    • Prevalence of chronic hepatitis B infection in Iran: a review article [2009]
  • Middle East Journal of Digestive Diseases
    • Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies [2016]
• Ireland
  • Health Protection Surveillance Centre
    • Hepatitis B
• Italy
  • New Microbiologica
    • The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy [2015]
• Laos
  • International Journal of Infectious Diseases
    • Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey [2015]
  • PLoS ONE
    • Chronic Hepatitis B Prevalence among Children and Mothers: Results from a Nationwide, Population-Based Survey in Lao People's Democratic Republic [2014]
• Mexico
  • Hepatology International
    • A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review [2009]
  • World Journal of Gastroenterology
    • HBV endemicity in Mexico is associated with HBV genotypes H and G [2013]
• Middle East, North Africa
  • Pathogens
    • Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update [2019]
• Moldova
  • Journal of Infection in Developing Countries
    • Epidemiology of hepatitis B virus infection in the Republic of Moldova [2008]
• Nepal
  • Tropical Gastroenterology
    • Chronic hepatitis B in Nepal: An Asian country with low prevalence of HBV Infection [2012]
• Nigeria
  • Nigerian Journal of Clinical Practice
    • Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis [2015]
• Norway
  • BMC Infectious Diseases
    • Molecular epidemiology of hepatitis B virus infection in Norway [2019]
• Pakistan
  • Virology Journal
    • Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes [2011]
• Philippines
  • World Journal of Hepatology
    • Hepatitis B infection among adults in the Philippines: A national seroprevalence study [2013]
• Poland
  • BMC Infectious Diseases
    • Significant proportion of acute hepatitis B in Poland in 2010–2014 attributed to hospital transmission: combining surveillance and public registries data [2018]
  • Hepatitis Monthly
    • Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013 [2016]
• Republic of Korea
  • Epidemiology and Health
    • Changes in seroprevalence of hepatitis B surface antigen and epidemiologic characteristics in the Republic of Korea, 1998-2013 [2015]
  • Korean Journal of Internal Medicine
    • The epidemiology of hepatitis B virus infection in Korea [2019]
  • Medicine
    • Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea [2015]
  • World Journal of Gastroenterology
    • Hepatitis B virus mutations related to liver disease progression of Korean patients [2014]
• Saudi Arabia
  • International Journal of Health Sciences
    • The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia [2013]
• Thailand
  • International Journal of Infectious Diseases
    • Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis [2016]
• Turkey
  • BMC Infectious Diseases
    • Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review [2011]
  • Euroasian Journal of Hepato-Gastroenterology
    • Epidemiology of Chronic Hepatitis B in Turkey [2018]
  • EuroSurveillance
    • Trends of hepatitis B notification rates in Turkey, 1990 to 2012 [2013]
• United Kingdom
  • Public Health England
    • Acute hepatitis B: guide to national enhanced surveillance
• United States of America
  • Centers for Disease Control and Prevention
    • Hepatitis B Screening and Prevalence Among Resettled Refugees — United States, 2006–2011 [2015]
  • Clinical Infectious Diseases
    • Epidemiology of Acute Hepatitis B in the United States From Population-Based Surveillance, 2006–2011 [2015]
  • Clinical Liver Disease
    • Epidemiology of Hepatitis B Virus Infection in the United States [2018]
• {Related topics}
  • Guidelines
    • Hepatitis: epidemiology
    • Hepatitis B

Hepatitis B: prevention, treatment, vaccine

• Asia
  • Discovery Medicine
    • The Impact of Anti-HBV Treatment on the Occurrence and Recurrence of Hepatocellular Carcinoma: Focus on Asian Studies [2015]
• Australia
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    • Treatment of chronic hepatitis B virus infection [2018]
  • Bulletin of the World Health Organization
    • Hepatitis B immunization for indigenous adults, Australia [2016]
  • Department of Health Australia
    • Hepatitis B | The Australian Immunisation Handbook [2018]
  • SA Health
    • Hepatitis B exposure - post exposure prophylaxis (PEP)
  • World Journal of Gastroenterology
    • Cost of treating chronic hepatitis B: Comparison of current treatment guidelines [2012]
• Bangladesh
  • Bangladesh Liver Journal
    • Guideline for treating hepatitis B virus infection in Bangladesh [2009]
• Brazil
  • Brazilian Journal of Infectious Diseases
    • Economic evaluation of treatments for chronic hepatitis B [2013]
    • Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B [2011]
• Canada
  • Government of Canada
    • Hepatitis B Vaccine
  • PLoS ONE
    • Hepatitis B Screening and Vaccination Strategies for Newly Arrived Adult Canadian Immigrants and Refugees: A Cost-Effectiveness Analysis [2013]
  • Public Health Agency of Canada
    • Summary of the NACI update on the recommended use of hepatitis B vaccine [2017]
    • Hepatitis B virus (HBV)
  • Public Health Ontario
    • Hepatitis B immunization - Technical Report [2017]
• China
  • BioScience Trends
    • Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices [2013]
  • Drug Design, Development and Therapy
    • Clinical utility of entecavir for chronic hepatitis B in Chinese patients [2013]
  • Hepatology
    • Contemporary Clinical Research of Traditional Chinese Medicines for Chronic Hepatitis B in China: An Analytical Review [2010]
  • Human Vaccines & Immunotherapeutics
    • Strategy vaccination against Hepatitis B in China [2015]
    • Healthy adult vaccination: An urgent need to prevent hepatitis B in China [2015]
  • International Journal of Clinical and Experimental Medicine
    • Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China [2015]
  • Medical Microbiology and Immunology
    • Antiviral therapy for chronic hepatitis B in China [2015]
  • Medicine
    • Estimating the impact of test-and-treat strategies on hepatitis B virus infection in China by using an age-structured mathematical model [2018]
  • PLoS ONE
    • Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China [2015]
  • World Journal of Gastroenterology
    • Seroepidemiology of hepatitis B virus infection and impact of vaccination [2015]
  • World Journal of Hepatology
    • Treating chronic hepatitis B virus: Chinese physicians’ awareness of the 2010 guidelines [2016]
• Denmark
  • EuroSurveillance
    • Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010 [2016]
• Europe
  • European Medicines Agency
    • Guideline on the clinical investigation of hepatitis B immunoglobulins [2015]
  • EuroSurveillance
    • Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014 [2018]
  • International Journal of Environmental Research and Public Health
    • The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review [2018]
• France
  • Digestive Diseases and Sciences
    • Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France [2016]
• Gambia
  • BMC Infectious Diseases
    • Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program [2014]
  • Lancet Global Health
    • Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis [2016]
    • Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study [2016]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Tenofovir alafenamide (chronic hepatitis B) – Benefit assessment according to §35a Social Code Book V [2017]
• International
  • Bulletin of the World Health Organization
    • Preventing hepatitis B virus infection: milestones and targets [2018]
    • Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis [2018]
    • Hepatitis B vaccination timing: results from demographic health surveys in 47 countries [2017]
    • Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? [2010]
  • Journal of Virus Eradication
    • Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries [2015]
  • Lancet Infectious Diseases
    • Requirements for global elimination of hepatitis B: a modelling study [2016]
• Iran
  • Hepatitis Monthly
    • A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model [2016]
    • Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study [2014]
  • Journal of Education and Health Promotion
    • The efficacy of hepatitis B vaccine in Iranian population: A systematic review and meta-analysis [2014]
• Ireland
  • Ireland's Health Services
    • Hepatitis B [2015]
• Italy
  • Clinical Microbiology and Infection
    • Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper Microbiology and Infection [2017]
  • Journal of Preventive Medicine and Hygiene
    • Lessons learnt over two decades of vaccination against hepatitis B in Italy [2015]
• Japan
  • World Journal of Gastroenterology
    • Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations [2015]
• Low and middle-income countries
  • BMC Infectious Diseases
    • Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries [2017]
• Netherlands
  • Netherlands Journal of Medicine
    • The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection [2012]
• Oman
  • American Journal of Tropical Medicine and Hygiene
    • Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination [2013]
• Pakistan
  • Virology Journal
    • An overview of treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients [2011]
• Papua New Guinea
  • American Journal of Tropical Medicine and Hygiene
    • Hepatitis B Surface Antigen Seroprevalence among Children in Papua New Guinea, 2012–2013 [2015]
• Poland
  • Clinical and Experimental Hepatology
    • Recommendations for the treatment of hepatitis B in 2017 [2017]
• Portugal
  • Acta Reumatológica Portuguesa
    • Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice [2011]
• Republic of Korea
  • Clinical and Experimental Vaccine Research
    • Paths toward hepatitis B immunization in South Korea and Taiwan [2013]
  • Gut and Liver
    • Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B [2016]
• Russia
  • PLoS ONE
    • Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia [2016]
• Tajikistan
  • Vaccine
    • Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan [2015]
• Thailand
  • PLoS ONE
    • The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation [2016]
• Turkey
  • Cost Effectiveness and Resource Allocation
    • Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey [2015]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Tenofovir disoproxil for the treatment of chronic hepatitis B [2009]
  • Public Health England
    • Hepatitis B: vaccine recommendations during supply constraints
    • Hepatitis B vaccine for at risk infants aide memoire
  • Value in Health
    • Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom [2015]
• United States of America
  • American Association for the Study of Liver Diseases
    • AASLD guidelines for treatment of chronic hepatitis B [2015]
  • American Gastroenterological Association
    • American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy [2015]
  • American Society of Clinical Oncology
    • Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update [2015]
  • American Society of Transplantation
    • Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management [2015]
  • BMC Research Notes
    • Management of infants born to women infected with hepatitis B in the military healthcare system [2013]
  • Centers for Disease Control and Prevention
    • Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant [2018]
    • Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices [2018]
    • Community-Based Services to Improve Testing and Linkage to Care Among Non–U.S.-Born Persons with Chronic Hepatitis B Virus Infection — Three U.S. Programs, October 2014–September 2017 [2018]
    • Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016 [2018]
    • CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management [2013]
    • Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2011]
    • A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults [2006]
    • A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: Immunization of Infants, Children, and Adolescents [2005]
    • Surveillance Manual | Hepatitis B
    • Hepatitis B Vaccination
• WHO
  • World Health Organization
    • Implementation of hepatitis B birth dose vaccination – worldwide, 2016 [2018]
    • Hepatitis B vaccines: WHO position paper – July 2017 [2017]
    • Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [2015]
    • Documenting the impact of Hepatitis B immunization: best practices for conducting a serosurvey [2011]
    • Hepatitis B vaccination and rheumatoid arthritis
    • Hepatitis B vaccination and multiple sclerosis
    • Hepatitis B vaccination and chronic fatigue syndrome
    • Hepatitis B and leukaemia
    • Hepatitis B (HepB3) - Immunization coverage estimates by country
    • Hepatitis B
• {Related topics}
  • Guidelines
    • Hepatitis B

Hepatitis C

• Asia
  • Korean Journal of Internal Medicine
    • A 2015 roadmap for the management of hepatitis C virus infections in Asia [2015]
• Australia
  • Australasian Sexual Health Alliance
    • Hepatitis C
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    • Nurses and Hepatitis C 2016 [2016]
    • Decision-Making in HCV [2016]
  • Australian Family Physician
    • Hepatitis C – an update [2013]
  • Department of Health Australia
    • Hepatitis C - CDNA National Guidelines for Public Health Units [2015]
    • Fourth National Hepatitis C Strategy 2014-2017 [2014]
    • Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings [2008]
  • Gastroenterological Society of Australia
    • Australian recommendations for the management of Hepatitis C virus infection: a consensus statement (August 2017) [2017]
  • NSW Ministry of Health
    • Hepatitis C
• Brazil
  • International Journal of Hepatology
    • Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective [2015]
• Canada
  • Canadian Family Physician
    • Primary care flow sheet for hepatitis C virus [2016]
  • Canadian Journal of Gastroenterology
    • The Second Canadian Symposium on Hepatitis C Virus: A call to action [2013]
  • Canadian Journal of Gastroenterology & Hepatology
    • The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C [2016]
    • Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan [2016]
  • Government of Alberta
    • Public health disease management guidelines : Hepatitis C acute (acute case) [2018]
    • Public health disease management guidelines : Hepatitis C (chronic case) [2018]
  • Government of Canada
    • Hepatitis C
• China
  • Journal of Clinical Gastroenterology
    • Current Challenges and the Management of Chronic Hepatitis C in Mainland China [2014]
• Egypt
  • International Journal of General Medicine
    • Hepatitis C in Egypt – past, present, and future [2016]
  • Lancet Global Health
    • Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study [2014]
• Europe
  • European Association for the Study of the Liver
    • EASL Clinical Practice Guidelines: Management of hepatitis C virus infection [2014]
  • Hepatology, Medicine and Policy
    • Urgent action to fight hepatitis C in people who inject drugs in Europe [2016]
  • WHO Regional Office for Europe
    • Fact sheet - Hepatitis C in the WHO European Region (2018) [2018]
• France
  • Hepatology, Medicine and Policy
    • Hepatitis C virus prevention and care for drug injectors: the French approach [2018]
  • World Journal of Hepatology
    • European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift [2018]
• Greece
  • World Journal of Gastroenterology
    • Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals [2019]
• India
  • Association of Physicians of India
    • Hepatitis C: Paradigm Shift in the Management [2017]
  • Journal of Clinical and Experimental Hepatology
    • Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India [2014]
• International
  • Clinical Microbiology and Infection
    • Hepatitis C: global epidemiology and strategies for control [2016]
  • International Liver Transplantation Society
    • International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients [2017]
    • International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates [2017]
  • International Network on Hepatitis in Substance Users
    • Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework [2018]
    • Recommendations for the management of hepatitis C virus infection among people who inject drugs [2015]
  • Journal of Virus Eradication
    • Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework [2018]
  • KDIGO
    • KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease [2018]
  • World Gastroenterology Organisation
    • Hepatitis C [2017]
• Iran
  • Hepatitis Monthly
    • Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline [2016]
• Italy
  • BMC Infectious Diseases
    • Proceedings of the Second Workshop of the Regional Study Group on HCV in the Calabria Region (Southern Italy). The virus-host-therapy pathway in HCV disease management: from bench to bedside in the era of Directly Actin [2012]
• Kuwait
  • Hepatic Medicine : Evidence and Research
    • Expert opinion on the management of hepatitis C infection in Kuwait [2018]
• Latin America
  • World Journal of Gastroenterology
    • Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America [2016]
• Mexico
  • Annals of Hepatology
    • Mexican consensus on the diagnosis and management of hepatitis C infection [2015]
• Middle East, North Africa
  • World Journal of Gastroenterology
    • Systematic overview of hepatitis C infection in the Middle East and North Africa [2018]
• Netherlands
  • Hepatology, Medicine and Policy
    • Strategies for achieving viral hepatitis C micro-elimination in the Netherlands [2018]
• New Zealand
  • Ministry of Health New Zealand
    • Hepatitis C
• Nordic countries
  • PLoS ONE
    • Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study [2018]
• Pakistan
  • Journal of Ayub Medical College Abbottabad
    • Diagnosis, Management and Prevention of Hepatitis C in Pakistan 2017 [2017]
• Portugal
  • BMC Infectious Diseases
    • Consensus for the integrated management of hepatitis C in Portugal [2014]
• Republic of Korea
  • Korean Association for the Study of the Liver
    • KASL clinical practice guidelines: management of hepatitis C [2016]
• Rwanda
  • Bulletin of the World Health Organization
    • Controlling hepatitis C in Rwanda: a framework for a national response [2018]
• Saudi Arabia
  • Saudi Journal of Gastroenterology
    • Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift [2016]
    • SASLT Practice Guidelines: Management of Hepatitis C Virus Infection [2012]
• Spain
  • Sociedad Española de Patología Digestiva
    • The position of the Sociedad Española de Patología Digestiva on the current situation of hepatitis C management in Spain [2014]
• Switzerland
  • Swiss Medical Weekly
    • Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions [2019]
• Turkey
  • Turkish Journal of Gastroenterology
    • Turkey 2017 Clinical Practice Guidelines on recommendations for screening diagnosing and managing hepatitis C virus [2017]
• United Kingdom
  • Journal of Public Health
    • An audit of hepatitis C service provision in a representative sample of prisons in England [2015]
  • Journal of Viral Hepatitis
    • Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK [2018]
  • Public Health England
    • Hepatitis C: guidance, data and analysis
  • Scottish Government
    • Hepatitis C Action Plan for Scotland: Phase II: May 2008 - March 2011 [2008]
  • Scottish Intercollegiate Guidelines Network
    • Management of hepatitis C [2013]
• United States of America
  • American Association for the Study of Liver Diseases
    • Recommendations for Testing, Managing, and Treating Hepatitis C
  • American College of Physicians
    • Performance Measurement: Hepatitis C
  • American Journal of Managed Care
    • Value of Expanding HCV Screening and Treatment Policies in the United States [2016]
  • American Society for Blood and Marrow Transplantation
    • Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations [2015]
  • Centers for Disease Control and Prevention
    • Hepatitis C Information
    • Hepatitis C
  • Endocrine Practice
    • Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy [2013]
  • Hepatitis C Online
    • Hepatitis C Online
  • Infectious Diseases Society of America
    • Recommendations for Testing, Managing, and Treating Hepatitis C [2017]
  • Minnesota Department of Health
    • Hepatitis C
  • New York State Department of Health AIDS Institute
    • Hepatitis care
  • North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
    • NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents [2012]
• WHO
  • World Health Organization
    • Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection [2018]
    • New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection [2016]
    • Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection: Updated version, April 2016 [2016]
    • Guidelines for the screening, care and treatment of persons with hepatitis C infection [2014]
    • Hepatitis C: Fact sheet
• {Related topics}
  • Guidelines
    • Hepatitis C: treatment
    • Hepatitis C: prevention, screening, diagnosis
    • Hepatitis C: epidemiology
    • Hepatitis

Hepatitis C: epidemiology

• Afghanistan
  • International Journal of Infectious Diseases
    • The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis [2015]
• Arab countries
  • Scientific World Journal
    • Hepatitis C Virus in Arab World: A State of Concern [2012]
• Arab states of the Persian Gulf
  • International Journal of Infectious Diseases
    • Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence [2016]
• Arctic countries
  • EuroSurveillance
    • Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014 [2018]
• Argentina
  • Hepatic Medicine : Evidence and Research
    • Hepatitis C in Argentina: epidemiology and treatment [2014]
  • World Journal of Hepatology
    • Hepatitis C virus infection in Argentina: Burden of chronic disease [2016]
• Australia
  • Department of Health Australia
    • Revised surveillance case definitions: hepatitis C - newly acquired and viral haemorrhagic fevers (quarantinable) [2015]
  • Hepatitis Monthly
    • Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis [2016]
• Belgium
  • BMC Public Health
    • Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up [2019]
  • PLoS ONE
    • Distribution of HCV genotypes in Belgium from 2008 to 2015 [2018]
• Brazil
  • Brazilian Journal of Infectious Diseases
    • Epidemiological aspects of hepatitis C in Brazil [2007]
  • Revista da Sociedade Brasileira de Medicina Tropical
    • Incidence of hepatitis C in Brazil [2015]
  • Revista de Saúde Pública
    • Prevalence of hepatitis C virus in Brazil’s inmate population: a systematic review [2015]
  • Scientific World Journal
    • Hepatitis C Worldwide and in Brazil: Silent Epidemic—Data on Disease including Incidence, Transmission, Prevention, and Treatment [2014]
• Cambodia
  • Scientific Reports
    • Molecular epidemiology of hepatitis C virus in Cambodia during 2016–2017 [2019]
• Cameroon
  • BMJ Open
    • Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis [2017]
• Canada
  • BMC Infectious Diseases
    • Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort [2016]
  • Canadian Journal of Gastroenterology & Hepatology
    • Burden of disease and cost of chronic hepatitis C virus infection in Canada [2014]
  • CMAJ Open
    • Identifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991-2010): an age-period-cohort analysis [2014]
  • Public Health Agency of Canada
    • Hepatitis C surveillance in Canada [2014]
• Central Asia
  • Scientific Reports
    • The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses [2019]
• China
  • BMC Infectious Diseases
    • Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis [2011]
  • Open Forum Infectious Diseases
    • Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis [2019]
• Croatia
  • World Journal of Gastroenterology
    • Epidemiology of hepatitis C in Croatia in the European context [2015]
• Cyprus
  • BMC Research Notes
    • Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts [2011]
• Denmark
  • BMC Infectious Diseases
    • Hepatitis C prevalence in Denmark -an estimate based on multiple national registers [2012]
• Eastern Mediterranean
  • Hepatitis Monthly
    • Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis [2016]
• Egypt
  • BMC Infectious Diseases
    • The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis [2013]
  • Hepatology
    • Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications [2014]
  • International Journal of Infectious Diseases
    • Risk factors associated with high prevalence rates of hepatitis C infection in Egypt [2014]
• Estonia
  • Medicina
    • A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia [2018]
• Europe
  • BMC Infectious Diseases
    • Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries [2018]
  • BMC Public Health
    • HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality [2009]
  • Digestive and Liver Disease
    • Epidemiology of hepatitis C in Europe [2014]
  • European Centre for Disease Prevention and Control
    • Hepatitis C - Annual Epidemiological Report for 2017 [2019]
  • Infectious Agents and Cancer
    • Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe [2016]
  • PLoS ONE
    • Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention [2014]
• France
  • EuroSurveillance
    • Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014 [2017]
• Ghana
  • BMC Infectious Diseases
    • Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis [2016]
• Greece
  • World Journal of Gastroenterology
    • Epidemiology of hepatitis C in Greece [2016]
• India
  • Journal of Clinical and Experimental Hepatology
    • Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India [2014]
• International
  • Infectious Agents and Cancer
    • Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa [2017]
  • Journal of Clinical Virology
    • Hepatitis C virus seroprevalence in the general female population from 8 countries [2015]
  • Journal of Hepatology
    • Global epidemiology and genotype distribution of the hepatitis C virus infection [2014]
  • PLoS ONE
    • The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis [2015]
  • Viruses
    • Epidemiology and Elimination of HCV-Related Liver Disease [2018]
  • World Journal of Gastroenterology
    • Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes [2016]
  • World Journal of Virology
    • Geographic integration of hepatitis C virus: A global threat [2016]
• Iran
  • Archives of Iranian Medicine
    • Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010 [2015]
  • Hepatitis Monthly
    • Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden [2016]
    • Prevalence of Hepatitis C Virus Genotypes in Iranian Patients: A Systematic Review and Meta-Analysis [2014]
  • Infectious Diseases of Poverty
    • Prevalence of hepatitis C virus among street children in Iran [2018]
  • International Journal of Infectious Diseases
    • High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001–2012) [2015]
  • Journal of Research in Medical Sciences
    • Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis [2014]
  • Scientific Reports
    • The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses [2018]
  • World Journal of Gastroenterology
    • Epidemiology of hepatitis C virus in Iran [2015]
• Ireland
  • EuroSurveillance
    • Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016 [2017]
  • Health Protection Surveillance Centre
    • Hepatitis C
• Italy
  • BMC Infectious Diseases
    • Update on epidemiology of HCV in Italy: focus on the Calabria Region [2014]
  • Medicine
    • Epidemiological burden estimates for pathologies with a nonconstant risk: an application to HCV in Italy according to age, Metavir score, and genotype [2016]
• Latin America and the Caribbean
  • International Journal of Public Health
    • Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis [2015]
• Lebanon
  • Hepatic Medicine : Evidence and Research
    • Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment [2018]
• Low-income countries
  • Infectious Diseases of Poverty
    • Epidemiology and management of hepatitis C virus infections in immigrant populations [2019]
• Macedonia
  • Balkan Journal of Medical Genetics
    • Study of the Hepatitis C Virus in the Republic of Macedonia [2012]
• Maghreb
  • PLoS ONE
    • The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses [2015]
• Malaysia
  • PLoS ONE
    • Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia [2015]
• Middle East
  • Hepatitis Monthly
    • The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis [2016]
• Middle East, North Africa
  • PLoS ONE
    • Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions [2017]
    • Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis [2016]
    • The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis [2015]
• Moldova
  • Journal of Infection in Developing Countries
    • Epidemiology of hepatitis C in the Republic of Moldova: achievements and remaining challenges in prevention and control [2016]
• Netherlands
  • Netherlands Journal of Medicine
    • The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms [2015]
• North Africa
  • Scientific World Journal
    • Hepatitis C Virus in North Africa: An Emerging Threat [2016]
• Pakistan
  • Hepatitis Monthly
    • Hepatitis C in Pakistan: A Review of Available Data [2010]
  • Royal Society Open Science
    • The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses [2018]
  • Virology Journal
    • Hepatitis C Virus Genotypes in Pakistan: a systemic review [2011]
  • World Journal of Gastroenterology
    • Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data [2016]
    • Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors [2009]
• Poland
  • Clinical and Experimental Hepatology
    • Prevalence of HCV genotypes in Poland – the EpiTer study [2016]
  • EuroSurveillance
    • Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014 [2017]
• Poland, Switzerland
  • Annals of Agricultural and Environmental Medicine
    • Hepatitis C virus epidemiology and prevention in Polish and Swiss population - similar and contrasting experiences [2016]
• Republic of Korea
  • Clinical and Molecular Hepatology
    • Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012 [2015]
  • Gut and Liver
    • Regional Distribution of Hepatitis C Virus Infection in the Republic of Korea, 2007–2011 [2014]
• Russia
  • Hepatic Medicine : Evidence and Research
    • Hepatitis C in the Russian Federation: challenges and future directions [2016]
• Spain
  • EuroSurveillance
    • Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain [2019]
• Sub-Saharan Africa
  • BMC Infectious Diseases
    • A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000–2013 [2016]
• Switzerland
  • European Journal of Public Health
    • Birth year distribution in reported hepatitis C cases in Switzerland [2014]
  • PLoS ONE
    • Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland [2015]
  • Swiss Medical Weekly
    • The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988–2015 [2018]
• Thailand
  • PLoS ONE
    • Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey [2016]
• United Kingdom
  • Public Health England
    • Hepatitis C in England and the UK
• Upper middle income countries
  • PLoS ONE
    • Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis [2019]
• United States of America
  • Centers for Disease Control and Prevention
    • State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016 [2017]
  • Hepatitis C Online
    • HCV Epidemiology in the United States [2018]
• {Related topics}
  • Guidelines
    • Hepatitis: epidemiology
    • Hepatitis C

Hepatitis C: prevention, screening, diagnosis

• Asia, Pacific
  • Asian Pacific Association for the Study of the Liver
    • APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing [2016]
• Australia
  • Department of Health Australia
    • National Hepatitis C Testing Policy May 2007 [2007]
• Brazil
  • Brazilian Journal of Infectious Diseases
    • How are HCV-infected patients being identified in Brazil: a multicenter study [2019]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Screening for Hepatitis C Virus: A Systematic Review [2017]
    • Acoustic Radiation Force Impulse Imaging for Diagnosis and Monitoring of Liver Fibrosis in Patients with Hepatitis C: A Review of Diagnostic Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines [2016]
    • Hepatitis C Polymorphism Testing: A Review of the Clinical Evidence [2014]
  • Canadian Task Force on Preventive Health Care
    • Recommendations on hepatitis C screening for adults [2017]
  • CMAJ : Canadian Medical Association Journal
    • A Canadian screening program for hepatitis C: Is now the time? [2013]
  • CMAJ Open
    • Systematic review of the accuracy of antibody tests used to screen asymptomatic adults for hepatitis C infection [2016]
  • Government of Alberta
    • Hepatitis C screening in Alberta : a health technology assessment [2016]
  • Public Health Agency of Canada
    • Hepatitis C virus
• Egypt
  • Centers for Disease Control and Prevention
    • Progress Toward Prevention and Control of Hepatitis C Virus Infection — Egypt, 2001–2012 [2012]
  • Journal of Clinical and Translational Hepatology
    • Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship [2014]
  • PLoS ONE
    • Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population [2016]
• Europe
  • International Journal of Environmental Research and Public Health
    • The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review [2018]
  • WHO Regional Office for Europe
    • What is the evidence for the effectiveness of interventions to reduce hepatitis C infection and the associated morbidity? [2006]
• France
  • PLoS ONE
    • The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014 [2015]
• High-income countries
  • World Journal of Hepatology
    • Comparison of hepatitis C virus testing recommendations in high-income countries [2018]
• International
  • BMJ Open
    • Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations [2016]
  • Forum for Collaborative HIV Research
    • Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile [2017]
    • High-priority target product profile for hepatitis C diagnosis in decentralized settings: Report of a consensus meeting [2015]
• Ireland
  • Department of Health Ireland
    • Hepatitis C Screening: National Clinical Guideline No. 15 [2017]
• Low and middle-income countries
  • BMC Infectious Diseases
    • Economic evaluation of HCV testing approaches in low and middle income countries [2017]
• Mexico
  • PLoS ONE
    • Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors [2016]
• Middle East, North Africa
  • Hepatology Communications
    • Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests [2019]
• Poland
  • BMJ Open
    • What affects response rates in primary healthcare-based programmes? An analysis of individual and unit-related factors associated with increased odds of non-response based on HCV screening in the general population in Poland [2016]
• Switzerland
  • PLoS ONE
    • Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations [2016]
  • Swiss Medical Weekly
    • Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland [2015]
• United Kingdom
  • EuroSurveillance
    • A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs [2018]
  • NIHR Journals Library
    • Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling - NCBI Bookshelf [2017]
  • Public Health England
    • SMI V 5: Screening for hepatitis C infection
    • Investigation of hepatitis C infection by antibody or combined antigen and antibody assay
• United States of America
  • Agency for Healthcare Research and Quality
    • Screening for Hepatitis C Virus Infection in Adults - Comparative Effectiveness Review Summary Guides for Clinicians [2013]
  • American Association for the Study of Liver Diseases
    • Testing, Evaluation, and Monitoring of Hepatitis C
  • American Gastroenterological Association
    • Hepatitis C Screening and Evaluation Clinical Decision Support Tool [2013]
  • American Journal of Public Health
    • Comparison of Current US Risk Strategy to Screen for Hepatitis C Virus With a Hypothetical Targeted Birth Cohort Strategy [2012]
  • Centers for Disease Control and Prevention
    • Vital Signs: Evaluation of Hepatitis C Virus Infection Testing and Reporting — Eight U.S. Sites, 2005–2011 [2013]
    • Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians [2013]
    • Locations and Reasons for Initial Testing for Hepatitis C Infection — Chronic Hepatitis Cohort Study, United States, 2006–2010 [2013]
    • Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945–1965 [2012]
    • Centers for Disease Control and Prevention Initiatives to Prevent Hepatitis C Virus Infection: A Selective Update [2012]
  • Hepatic Medicine : Evidence and Research
    • Ending hepatitis C in the United States: the role of screening [2014]
  • Journal of Clinical Medicine Research
    • Hepatitis C Virus in the US Military Retiree Population: To Screen, or Not to Screen? [2015]
  • Seminars in Dialysis
    • Hepatitis C Virus Screening and Management of Seroconversions in Hemodialysis Facilities [2013]
  • U.S. Preventive Services Task Force
    • Hepatitis C: Screening [2013]
• WHO
  • World Health Organization
    • Collaborative study to evaluate the proposed 4th WHO international standards for Hepatitis C Virus (HCV) for Nucleic Acid Amplification Technology (NAT)-Based Assays [2011]
• {Related topics}
  • Guidelines
    • Hepatitis C

Hepatitis C: treatment

• Albania
  • Virology Journal
    • Treatment and follow up of children with chronic hepatitis C in Albania [2012]
• Asia, Pacific
  • Asian Pacific Association for the Study of the Liver
    • APASL consensus statements and recommendation on treatment of hepatitis C [2016]
  • Journal of Virus Eradication
    • The hepatitis C treatment revolution: how to avoid Asia missing out [2015]
• Australia
  • Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
    • HCV Treatments Quick Reference Tool [2017]
  • Australian Family Physician
    • A practical overview of the treatment of chronic hepatitis C virus infection [2016]
  • Australian Journal of General Practice
    • Insights into the management of chronic hepatitis C [2018]
  • Australian Prescriber
    • Treating hepatitis C – what’s new? [2015]
  • ClinicoEconomics and Outcomes Research
    • The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia [2017]
  • SA Health
    • Hepatitis C community prescribing
  • UNSW - The Kirby Institute for infection and immunity in society
    • Real world efficacy of antiviral therapy in chronic hepatitis C (REACH-C) in Australia [2017]
    • Monitoring hepatitis C treatment uptake in Australia [2017]
• Australia, New Zealand
  • Australasian Hepatology Association
    • The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals [2016]
• Brazil
  • BMC Public Health
    • The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy [2016]
  • Brazilian Journal of Infectious Diseases
    • Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil [2018]
  • Ciência & Saúde Coletiva
    • Public procurement of hepatitis C medicines in Brazil from 2005 to 2015 [2017]
  • Cost Effectiveness and Resource Allocation
    • Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil [2013]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Drugs for Chronic Hepatitis C Infection: Cost-Effectiveness Analysis [2016]
    • Drugs for Chronic Hepatitis C Infection: Clinical Review [2016]
    • Ledipasvir/Sofosbuvir (Harvoni): For the Treatment of Chronic Hepatitis C Virus (CHC) G1 Infection in Adults [2015]
    • Holkira (Ombitasvir/Paritaprevir/ Ritonavir with Dasabuvir) and Harvoni (Ledipasvir/Sofosbuvir) for Chronic Hepatitis C: A Review of the Clinical Evidence [2015]
    • Drugs for Chronic Hepatitis C Infection: Recommendations Report [2015]
    • Triple Therapy for Hepatitis C in Previous Non-responders: A Review of the Clinical Effectiveness and Safety [2014]
    • Treatments for Patients with Genotype 1 Chronic Hepatitis C: A Review of Evidence-based Guidelines [2014]
    • Interferon-free Regimens for Genotype 1 Chronic Hepatitis C: A Review of the Clinical Evidence and Cost-Effectiveness [2014]
  • Canadian Association for the Study of the Liver
    • The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver [2018]
    • An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver [2015]
  • Canadian Journal of Gastroenterology & Hepatology
    • Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: A policy statement and implementation guideline [2014]
  • CMAJ Open
    • Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis [2017]
    • Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study [2016]
  • PLoS ONE
    • Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs? [2015]
• China
  • PLoS ONE
    • Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data [2016]
  • World Journal of Gastroenterology
    • Current treatment of chronic hepatitis C in China: Dilemma and potential problems [2016]
• Egypt
  • Alimentary Pharmacology & Therapeutics
    • Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies [2015]
• Europe
  • BMC Infectious Diseases
    • Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries [2014]
    • A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region [2014]
  • BMC Public Health
    • Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe [2019]
  • European Association for the Study of the Liver
    • EASL Recommendations on Treatment of Hepatitis C 2018 [2018]
    • Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015 [2015]
  • European Society for Paediatric Gastroenterology Hepatology and Nutrition
    • Guidance for Clinical Trials for Children and Adolescents With Chronic Hepatitis C [2011]
  • Frontiers in Pharmacology
    • Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future [2016]
  • Harm Reduction Journal
    • Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries [2019]
  • WHO Regional Office for Europe
    • Barriers and facilitators to hepatitis C treatment for people who inject drugs. A qualitative study [2012]
• France
  • BMC Infectious Diseases
    • Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015 [2017]
• Germany
  • BMC Infectious Diseases
    • Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany - an application of the efficiency frontier approach [2015]
  • BMJ Open Gastroenterology
    • Economic study of the value of expanding HCV treatment capacity in Germany [2017]
  • Institute for Quality and Efficiency in Health Care
    • Glecaprevir/pibrentasvir (chronic hepatitis C) – Benefit assessment according to § 35a Social Code Book V [2017]
    • Elbasvir/grazoprevir (chronic hepatitis C) - Benefit assessment according to §35a Social Code Book V [2017]
  • PLoS ONE
    • Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany [2017]
    • Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors – Results from the PAN Study [2016]
  • Visceral Medicine
    • The New Era of Interferon-Free Treatment of Chronic Hepatitis C [2015]
• India
  • Journal of Clinical and Experimental Hepatology
    • Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015 [2015]
• International
  • Autoimmune Diseases
    • International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement [2017]
  • Bulletin of the World Health Organization
    • Treatment of people diagnosed with chronic hepatitis C virus infection [2018]
    • Access to hepatitis C medicines [2015]
  • Clinical Pharmacology & Therapeutics
    • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-a–Based Regimens [2014]
  • Forum for Collaborative HIV Research
    • Hepatitis C virus drug resistance–associated substitutions: State of the art summary [2015]
    • Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy [2013]
    • Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents [2012]
    • Clinically Relevant HCV Drug Resistance Mutations Figure and Tables [2012]
  • PLoS Medicine
    • Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis [2016]
  • Scientific Reports
    • Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data [2016]
• Italy
  • ClinicoEconomics and Outcomes Research
    • Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service [2017]
    • Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives [2016]
  • Digestive and Liver Disease
    • Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF) [2013]
• Japan
  • Drug Design, Development and Therapy
    • Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study [2016]
  • Journal of Gastroenterology
    • Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines [2013]
  • Viruses
    • HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy [2015]
  • World Journal of Hepatology
    • Natural interferon-beta treatment for patients with chronic hepatitis C in Japan [2015]
• Latin America
  • Annals of Hepatology
    • Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C [2014]
• Low and middle-income countries
  • Bulletin of the World Health Organization
    • Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis [2012]
  • Treatment Action Group
    • Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries [2015]
  • World Health Organization
    • Progress report on access to hepatitis C treatment: focus on overcoming barriers in low- and middle-income countries [2018]
• Netherlands
  • Netherlands Journal of Medicine
    • Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era [2014]
    • Treatment of hepatitis C monoinfection in adults--Dutch national guidelines [2013]
  • PLoS ONE
    • Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study [2016]
• Pakistan
  • Asian Pacific Journal of Tropical Medicine
    • Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan: Treatment response, side effects and future prospective [2015]
• Poland
  • Clinical and Experimental Hepatology
    • Recommendations for the treatment of hepatitis C in 2017 [2017]
    • Efficacy of HCV treatment in Poland at the turn of the interferon era – the EpiTer study [2016]
  • Przeglad Epidemiologiczny - Epidemiological Review
    • Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015 [2015]
    • Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014 [2014]
• Republic of Korea
  • Clinical and Molecular Hepatology
    • Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL [2018]
  • Korean Association for the Study of the Liver
    • 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C [2018]
• Romania
  • Journal of Gastrointestinal and Liver Diseases
    • Position paper on treatment of hepatitis C in Romania, 2017. Part one [2017]
    • Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two [2017]
• Saudi Arabia
  • Saudi Journal of Gastroenterology
    • SASLT guidelines: Update in treatment of Hepatitis C virus infection [2016]
• Singapore
  • Ministry of Health Singapore
    • Direct-acting antiviral agents for treating genotype 1 chronic hepatitis C [2018]
• Spain
  • Health Policy
    • The merry-go-round of approval, pricing and reimbursement of drugs against the Hepatitis C virus infection in Spain - Health Policy [2016]
  • Revista Española de Sanidad Penitenciaria
    • Treatment guidelines for Hepatitis C in Spain [2015]
• Sweden
  • Infectious Diseases
    • Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations [2015]
• Switzerland
  • PLoS ONE
    • Drug Pricing Evolution in Hepatitis C [2016]
    • Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C [2015]
• Taiwan
  • Journal of the Formosan Medical Association
    • Hepatitis C virus infection in Taiwan: Past, present, and future [2016]
  • Kaohsiung Journal of Medical Sciences
    • A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan [2017]
  • Medicine
    • Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C [2015]
• Thailand
  • BMC Gastroenterology
    • Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6 [2016]
  • PLoS ONE
    • Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era [2016]
• Turkey
  • Balkan Medical Journal
    • Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study [2016]
  • Turkish Journal of Gastroenterology
    • Recommendation for treatment of hepatitis C virus infection [2017]
• United Kingdom
  • Alimentary Pharmacology & Therapeutics
    • 2014 UK consensus guidelines – hepatitis C management and direct-acting anti-viral therapy [2014]
  • Health Protection Scotland
    • National Clinical Guidelines for the treatment of HCV in adults [2018]
  • Health Technology Assessment
    • The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation [2014]
  • Medicines and Healthcare products Regulatory Agency
    • Direct-acting antivirals to treat chronic hepatitis C: risk of interaction with vitamin K antagonists and changes in INR [2017]
    • Direct-acting antiviral interferon-free regimens to treat chronic hepatitis C: risk of hepatitis B reactivation [2017]
  • National Institute for Health and Care Excellence
    • Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C [2018]
    • Glecaprevir–pibrentasvir for treating chronic hepatitis C [2018]
    • Sofosbuvir–velpatasvir for treating chronic hepatitis C [2017]
    • Elbasvir–grazoprevir for treating chronic hepatitis C [2016]
    • Sofosbuvir for treating chronic hepatitis C [2015]
    • Simeprevir in combination with sofosbuvir for treating genotype 1 or 4 chronic hepatitis C [2015]
    • Simeprevir in combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C [2015]
    • Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C [2015]
    • Ledipasvir–sofosbuvir for treating chronic hepatitis C [2015]
    • Daclatasvir for treating chronic hepatitis C [2015]
    • Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people [2013]
    • Telaprevir for the treatment of genotype 1 chronic hepatitis C [2012]
    • Boceprevir for the treatment of genotype 1 chronic hepatitis C [2012]
    • Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C [2010]
  • NHS England
    • Treatment of chronic Hepatitis C in patients with cirrhosis [2015]
  • PLoS ONE
    • Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections [2015]
  • Public Health England
    • Antiviral resistance testing in the management of hepatitis C
• United States of America
  • Agency for Healthcare Research and Quality
    • Treatment for Hepatitis C Virus Infection in Adults [2013]
    • Comparative Effectiveness of Treatments for Chronic Hepatitis C Virus Infection in Adults [2012]
  • American Association for the Study of Liver Diseases
    • An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [2011]
    • Retreatment of Persons in Whom Prior Therapy Failed
    • Initial Treatment of HCV Infection
  • American Gastroenterological Association
    • American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection [2017]
  • American Journal of Managed Care
    • Costs and Spillover Effects of Private Insurers’ Coverage of Hepatitis C Treatment [2016]
    • Accessing the Cure: Helping Patients With Hepatitis C Overcome Barriers to Care [2016]
  • BMC Gastroenterology
    • Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US [2015]
  • Infectious Agents and Cancer
    • Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States [2016]
  • Infectious Diseases and Therapy
    • Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need [2016]
  • Liver International
    • HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape [2015]
  • North American Journal of Medical Sciences
    • Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies [2016]
  • Open Forum Infectious Diseases
    • The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets [2018]
  • PLoS ONE
    • The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis [2014]
  • U.S. Department of Veterans Affairs
    • A Population Approach to Disease Management: Hepatitis C Direct-Acting Antiviral Use in a Large Health Care System [2014]
    • Assessment of Alternative Treatment Strategies for Chronic Genotype 1 Hepatitis C [2013]
• WHO
  • World Health Organization
    • Global report on access to hepatitis C treatment - Focus on overcoming barriers [2016]
• {Related topics}
  • Guidelines
    • Hepatitis C

Hepatitis D

• Asia, Pacific
  • World Journal of Gastroenterology
    • Hepatitis D: Scenario in the Asia-Pacific region [2010]
• Australia
  • NSW Ministry of Health
    • Hepatitis D
• Canada
  • Public Health Agency of Canada
    • Hepatitis D Virus
• International
  • Current Gastroenterology Reports
    • Hepatitis Delta: Epidemiology, Diagnosis and Management 36 Years After Discovery [2014]
  • World Journal of Hepatology
    • Hepatitis delta virus: Making the point from virus isolation up to 2014 [2015]
• North Africa
  • Scientific World Journal
    • The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis [2018]
• Romania
  • Journal of Gastrointestinal and Liver Diseases
    • Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors [2015]
• South America
  • Revista da Sociedade Brasileira de Medicina Tropical
    • Hepatitis Delta Prevalence in South America: A Systematic Review and Meta-Analysis [2019]
• Turkey
  • Turkish Journal of Gastroenterology
    • Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines [2017]
• United States of America
  • Centers for Disease Control and Prevention
    • Hepatitis D Information
• WHO
  • World Health Organization
    • Hepatitis D: Fact sheet
• {Related topics}
  • Guidelines
    • Hepatitis

Hepatitis E

• Africa
  • BMC Infectious Diseases
    • A systematic review of the epidemiology of hepatitis E virus in Africa [2014]
• Australia
  • NSW Ministry of Health
    • Hepatitis E
  • Pathology
    • Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history? [2015]
  • Western Pacific Surveillance and Response Journal
    • Hepatitis E in a food handler – a rapid risk assessment to guide the public health response [2014]
• Austria
  • PLoS ONE
    • Hepatitis E Virus Seroprevalence in Austrian Adults: A Nationwide Cross-Sectional Study among Civilians and Military Professionals [2014]
• Belgium
  • EuroSurveillance
    • Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017 [2019]
• Brazil
  • Revista da Sociedade Brasileira de Medicina Tropical
    • Hepatitis E virus infection in Brazil: results of laboratory-based surveillance from 1998 to 2013 [2015]
• Canada
  • Government of Alberta
    • Public health disease management guidelines : hepatitis E [2018]
  • Public Health Agency of Canada
    • Hepatitis E virus
• Central African Republic
  • Emerging Infectious Diseases
    • Imported Hepatitis E Virus, Central African Republic, 2011 [2013]
    • Hepatitis E, Central African Republic [2008]
• China
  • Human Vaccines & Immunotherapeutics
    • Health economic evaluation of immunization strategies of hepatitis E vaccine for elderly population [2017]
  • PLoS ONE
    • Acute, Recent and Past HEV Infection among Voluntary Blood Donors in China: A Systematic Review and Meta-Analysis [2016]
    • Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005–2006 [2014]
• Cuba
  • Emerging Infectious Diseases
    • Hepatitis E Virus Genotype 1, Cuba [2008]
• Developing countries
  • Viruses
    • Transmission of Hepatitis E Virus in Developing Countries [2016]
• Europe
  • European Association for the Study of the Liver
    • EASL Clinical Practice Guidelines on hepatitis E virus infection [2018]
  • European Centre for Disease Prevention and Control
    • Hepatitis E in the EU/EEA, 2005-2015 [2017]
  • European Medicines Agency
    • Reflection paper on viral safety of plasma-derived medicinal products with respect to Hepatitis E virus [2016]
  • European Society for Paediatric Gastroenterology Hepatology and Nutrition
    • Hepatitis E in Children: A Position Paper by the ESPGHAN Hepatology Committee [2016]
  • EuroSurveillance
    • Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015 [2017]
    • Hepatitis E and blood donation safety in selected European countries: a shift to screening? [2017]
  • International Journal of Molecular Sciences
    • Epidemiology of Hepatitis E Virus in European Countries [2015]
  • Journal of Clinical Virology
    • Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15 [2016]
  • Viruses
    • Hepatitis E Seroprevalence in Europe: A Meta-Analysis [2016]
• Germany
  • Deutsches Ärzteblatt International
    • Hepatitis E in Germany—an Under-Reported Infectious Disease [2014]
  • EuroSurveillance
    • Case-control study on risk factors for acute hepatitis E in Germany, 2012 to 2014 [2018]
    • Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 [2016]
• Ghana
  • Infectious Diseases of Poverty
    • Hepatitis E infection among Ghanaians: a systematic review [2017]
• India
  • Indian Journal of Medical Microbiology
    • Hepatitis E virus infection: An old virus with a new story! [2018]
• International
  • World Journal of Gastroenterology
    • Hepatitis E: Discovery, global impact, control and cure [2016]
  • World Journal of Virology
    • Hepatitis E virus infection: Epidemiology and treatment implications [2015]
• Iran
  • Journal of Clinical and Translational Hepatology
    • Epidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General Overview [2016]
  • Middle East Journal of Digestive Diseases
    • Seroprevalence of Hepatitis E Virus in Iran: A Systematic Review and Meta-analysis [2016]
  • World Journal of Gastroenterology
    • Epidemiology of hepatitis E virus in Iran [2016]
• Ireland
  • Health Protection Surveillance Centre
    • Hepatitis E
• Israel
  • Emerging Infectious Diseases
    • Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010 [2015]
  • World Journal of Gastroenterology
    • Hepatitis E in Israel: A nation-wide retrospective study [2016]
• Italy
  • BMJ Open
    • Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy [2015]
  • EuroSurveillance
    • Hepatitis E in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016 [2018]
  • Journal of Infection and Public Health
    • Hepatitis E in Italy: A silent presence [2017]
• Latin America
  • World Journal of Gastroenterology
    • Hepatitis E virus: An ancient hidden enemy in Latin America [2016]
• Latin America and the Caribbean
  • Revista Panamericana de Salud Pública
    • Challenges in research and management of hepatitis E virus infection in Cuba, Mexico, and Uruguay [2018]
• Malawi
  • Emerging Infectious Diseases
    • Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi [2015]
• Netherlands
  • PLoS ONE
    • Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands [2018]
    • Hepatitis E prevalence in a sexual high-risk population compared to the general population [2018]
  • Transfusion
    • Past and present of hepatitis E in the Netherlands [2014]
• Papua New Guinea
  • Emerging Infectious Diseases
    • Hepatitis E Virus Infection, Papua New Guinea, Fiji, and Kiribati, 2003–2005 [2014]
• Republic of Korea
  • BMC Infectious Diseases
    • Hepatitis E Virus (HEV) Seroprevalence in the general population of the Republic of Korea in 2007-2009: a nationwide cross-sectional study [2014]
  • Journal of Preventive Medicine and Public Health
    • A Survey on the Status of Hepatitis E Virus Infection Among Slaughterhouse Workers in South Korea [2015]
• Spain
  • Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
    • Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) [2018]
• Switzerland
  • EuroSurveillance
    • Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016 [2018]
• United Kingdom
  • British Transplantation Society
    • Guidelines for Hepatitis E and solid organ transplantation [2017]
  • Department of Health and Social Care
    • Protecting patients from getting hepatitis E through transfusion or transplantation
  • EuroSurveillance
    • Eurosurveillance | Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening [2019]
    • Hepatitis E virus (HEV) in Scotland: evidence of recent increase in viral circulation in humans [2018]
  • Public Health England
    • Screening for hepatitis E infection
    • SMI V 53: screening and monitoring for hepatitis E infection
    • Hepatitis E: symptoms, transmission, prevention, treatment
    • Hepatitis E: health protection response to reports of infection
    • Hepatitis E: guidance, data and analysis
• United States of America
  • Centers for Disease Control and Prevention
    • Hepatitis E [2016]
    • Hepatitis E Information
  • Journal of Infectious Diseases
    • Decline in Hepatitis E Virus Antibody Prevalence in the United States From 1988–1994 to 2009–2010 [2014]
• WHO
  • World Health Organization
    • Hepatitis E vaccine. WHO position paper [2015]
    • Waterborne Outbreaks of Hepatitis E: recognition, investigation and control [2014]
    • Collaborative study to establish a World Health Organization international standard for Hepatitis E virus RNA for Nucleic Acid Amplification Technology (NAT)-Based Assays [2011]
    • The global prevalence of hepatitis E virus infection and susceptibility: a systematic review [2010]
    • Hepatitis E: Fact sheet
• {Related topics}
  • Guidelines
    • Hepatitis

Hepatitis G

• Burkina Faso
  • Mediterranean Journal of Hematology and Infectious Diseases
    • Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa [2013]
• Iran
  • Hepatitis Monthly
    • Evaluation of Prevalence and Risk Factors of Hepatitis G Virus Infection Among Hemodialysis Patients Referred to Iranian Army Hospitals in Tehran During 2012-2013 [2015]
  • International Journal of Preventive Medicine
    • Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan-Iran [2014]
  • Jundishapur Journal of Microbiology
    • Prevalence of Hepatitis G Virus Among Hemodialysis and Kidney Transplant Patients in Khuzestan Province, Iran [2015]
• Saudi Arabia
  • Journal of Infection in Developing Countries
    • Hepatitis G virus in Saudi blood donors and chronic hepatitis B and C patients [2014]
• {Related topics}
  • Guidelines
    • Hepatitis

Hepatitis: epidemiology

• Australia
  • Medical Journal of Australia
    • National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia [2006]
  • UNSW - The Kirby Institute for infection and immunity in society
    • Hepatitis B and C in Australia Annual Surveillance Report Supplement 2016 [2016]
• Brazil
  • Annals of Hepatology
    • Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study [2017]
  • Cadernos de Saúde Pública
    • Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil [2010]
• Burkina Faso
  • Bulletin of the World Health Organization
    • Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study [2018]
• Canada
  • Public Health Agency of Canada
    • Report on Hepatitis B and C in Canada: 2014 [2017]
• China
  • Emerging Infectious Diseases
    • Changing Epidemiology of Hepatitis A and Hepatitis E Viruses in China, 1990–2014 [2017]
  • International Journal of Environmental Research and Public Health
    • Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies [2018]
• Egypt
  • BMC Infectious Diseases
    • Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001–17 [2019]
• Ethiopia
  • BMC Infectious Diseases
    • Hepatitis viruses in Ethiopia: a systematic review and meta-analysis [2016]
• Europe
  • BMC Infectious Diseases
    • Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups [2018]
    • Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening [2013]
  • European Centre for Disease Prevention and Control
    • Hepatitis B and C epidemiology in selected population groups in the EU/EEA [2018]
    • EU/EEA capacity for the surveillance of hepatitis B and C using molecular methods [2018]
    • Systematic review on hepatitis B and C prevalence in the EU/EEA [2016]
    • Epidemiological assessment of hepatitis B and C among migrants in the EU/EEA [2016]
  • EuroSurveillance
    • Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012 [2016]
    • Survey of surveillance systems and select prevention activities for hepatitis B and C, European Union/European Economic Area, 2009 [2015]
    • Surveillance and epidemiology of hepatitis B and C in Europe - a review [2008]
• India
  • Centers for Disease Control and Prevention
    • Viral Hepatitis Surveillance — India, 2011–2013 [2015]
  • Indian Journal of Medical Microbiology
    • Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis [2017]
• Indonesia
  • Euroasian Journal of Hepato-Gastroenterology
    • Epidemiology of Hepatitis B and C in Republic of Indonesia [2017]
• International
  • Hepatology
    • World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma [2015]
  • Lancet
    • The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 [2016]
  • World Journal of Clinical Cases
    • Update on global epidemiology of viral hepatitis and preventive strategies [2018]
• Ireland
  • Health Protection Surveillance Centre
    • Hepatitis
• Italy
  • World Journal of Gastroenterology
    • Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data [2017]
• Libya
  • BMC Infectious Diseases
    • Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey [2014]
• Malawi
  • BMC Infectious Diseases
    • Epidemiology of hepatitis B, C and D in Malawi: systematic review [2018]
• Nepal
  • Hepatology, Medicine and Policy
    • Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973–2017) [2018]
• Pakistan
  • Centers for Disease Control and Prevention
    • Establishment of a Viral Hepatitis Surveillance System --- Pakistan, 2009--2011 [2011]
• Republic of the Congo
  • BMC Research Notes
    • Epidemiology of viral hepatitis in the Republic of Congo: review [2017]
• Saudi Arabia
  • BMC Public Health
    • Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: The need for national guidelines for health students [2014]
  • Saudi Journal of Gastroenterology
    • Epidemiology of Viral Hepatitis in Saudi Arabia: Are We Off the Hook? [2012]
• Somalia
  • World Journal of Gastroenterology
    • Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study [2018]
• Spain
  • Revista Española de Enfermedades Digestivas
    • Prevalence of hepatitis B and C in Spain - further data are needed [2013]
• United Kingdom
  • British Association for Sexual Health and HIV
    • Guidance on reporting cases of hepatitis in GU medicine clinics [2012]
• WHO
  • World Health Organization
    • Consolidated strategic information guidelines for viral hepatitis planning and tracking progress towards elimination: web annex 3: protocol for surveillance of the fraction of cirrhosis and hepatocellular carcinoma attributable to viral hepatitis in clinical centres of excellence [2019]
    • Consolidated strategic information guidelines for viral hepatitis planning and tracking progress towards elimination: web annex 2: template protocol for surveys to estimate the prevalence of biomarkers of infection with the hepatitis viruses [2019]
    • Consolidated strategic information guidelines for viral hepatitis planning and tracking progress towards elimination: web annex 1: standard operating procedures for enhanced reporting of cases of acute hepatitis [2019]
    • Technical considerations and case definitions to improve surveillance for viral hepatitis [2016]
    • Global policy report on the prevention and control of viral hepatitis [2013]
• {Related topics}
  • Guidelines
    • Hepatitis C: epidemiology
    • Hepatitis B: epidemiology
    • Hepatitis A: epidemiology
    • Hepatitis